Health News

FDA OKs New Hep C Rx
The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients.
Women, Sleep and Diabetes Risk
Ladies, catching the recommended amount of ZZZ's may be vitally important to your health.
New Kidney Transplant Rx Shows Promise
Keeping transplanted kidneys working properly can be a tough job — and one that may have just gotten a little easier.
How Diet Could Affect Dialysis
Dialysis can be a lifesaver for patients with kidney failure. But what if there was a way to prevent the need for dialysis in the first place?
Approved: A New Rx for Liposarcoma
This week, the US Food and Drug Administration (FDA) approved Eisai Inc.'s drug derived from sea sponge for a rare type of soft tissue cancer.
FDA Approves New Liposarcoma Rx
The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma) that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who received prior chemotherapy that contained an anthracycline drug.
A New Type of ADHD Rx
Lots of kids have trouble swallowing pills. And lots of kids have attention deficit hyperactivity disorder (ADHD). For kids who fall into both groups, there may be a new treatment option.
Weight Loss: Diet With a Side of Exercise
Exercise is important when you're trying to lose weight, but it may not be the only factor.
New ADHD Rx Gets FDA Nod
Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company with a late‐stage pipeline of innovative extended-release (XR) product candidates for the treatment of attention-deficit/hyperactivity disorder (ADHD), today announced that the U.S. Food and Drug Administration (FDA) approved Adzenys XR-ODT™ for the treatment of ADHD in patients six years and older. With this approval, Adzenys XR-ODT is the first and only extended-release orally disintegrating tablet (ODT) for the treatment of ADHD.
Caffeine Drinkers May Not Miss a Beat
Proponents and opponents of caffeine have long been weighing in on its health effects. Caffeine-lovers will be happy to know that one common caffeine criticism may no longer be on the table.
<< first174175176177178179180181182last >>

REFINE